migraine Archives - LifeScienceHistory.com

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for Acute Treatment of Migraine

Disease | FDA | Neurology | Pharmaceutical | Therapeutics

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for Acute Treatment of Migraine

On May 15, 2025, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya®…

FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine

Biotechnology | Disease | Neurology | Pharmaceutical | Therapeutics

FDA approved Lundbeck’s VYEPTI™ – the first and only intravenous preventive treatment for migraine

On Feb. 21, 2020, Lundbeck announced that VYEPTI™ (eptinezumab-jjmr) had been approved by the U.S. Food and Drug…

Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion

Biotechnology | Disease | Neurology | Pharmaceutical | Therapeutics

Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion

On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…

$10 million gift to UCLA from Wendy and Leonard Goldberg largest ever to support migraine research

Biotechnology | Neurology | Non-Profit Research | Therapeutics

$10 million gift to UCLA from Wendy and Leonard Goldberg largest ever to support migraine research

On Dec. 8, 2015, the University of California, Los Angeles (UCLA) Health Sciences announced it had received a…